ARCH Venture Fund X, L.P.
10% Owner
Latest Insider Transactions
9 transactions (past 365 days)
| 2026-11-03 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | 10% Owner | Conversion | 259,948 | $0.00 | $0 |
| 2026-11-03 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | 10% Owner | Purchase | 66,667 | $15.00 | $1,000,005 |
| 2026-11-03 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | 10% Owner | Conversion | 214,355 | $0.00 | $0 |
| 2026-11-03 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | 10% Owner | Purchase | 66,666 | $15.00 | $999,990 |
| 2026-11-03 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | 10% Owner | Conversion | 295,490 | $0.00 | $0 |
| 2026-11-03 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | 10% Owner | Conversion | 286,304 | $0.00 | $0 |
| 2026-11-03 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | 10% Owner | Conversion | 298,258 | $0.00 | $0 |
| 2026-11-03 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | 10% Owner | Purchase | 1,200,000 | $15.00 | $18,000,000 |
| 2026-11-03 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | 10% Owner | Conversion | 187,182 | $0.00 | $0 |
ASPE
10% Owner
Conversion
$0
259,948 shares @ $0.00
Filed 2026-11-03Trade 2026-11-02
Aspen Neuroscience, Inc.ASPE
10% Owner
Purchase
$1M
66,667 shares @ $15.00
Filed 2026-11-03Trade 2026-11-02
Aspen Neuroscience, Inc.ASPE
10% Owner
Conversion
$0
214,355 shares @ $0.00
Filed 2026-11-03Trade 2026-11-02
Aspen Neuroscience, Inc.ASPE
10% Owner
Purchase
$1000K
66,666 shares @ $15.00
Filed 2026-11-03Trade 2026-11-02
Aspen Neuroscience, Inc.ASPE
10% Owner
Conversion
$0
295,490 shares @ $0.00
Filed 2026-11-03Trade 2026-11-02
Aspen Neuroscience, Inc.ASPE
10% Owner
Conversion
$0
286,304 shares @ $0.00
Filed 2026-11-03Trade 2026-11-02
Aspen Neuroscience, Inc.ASPE
10% Owner
Conversion
$0
298,258 shares @ $0.00
Filed 2026-11-03Trade 2026-11-02
Aspen Neuroscience, Inc.ASPE
10% Owner
Purchase
$18M
1,200,000 shares @ $15.00
Filed 2026-11-03Trade 2026-11-02
Aspen Neuroscience, Inc.ASPE
10% Owner
Conversion
$0
187,182 shares @ $0.00
Filed 2026-11-03Trade 2026-11-02
Aspen Neuroscience, Inc.